Latest filing published 27 Aug 2025 for Ascletis Pharma Inc. - B, €42.7M.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 13 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +305.4%Entry HK$3.34 · Close at T+365 HK$13.54
- +344.7%Entry HK$2.84 · Close at T+365 HK$12.63
- -4.2%Entry HK$3.12 · Close at T+365 HK$2.99
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Wu Jinzi Jason: trading record in brief
Filings by Wu Jinzi Jason span 2 companies, the busiest being Ascletis Pharma Inc. - B and Sagimet Biosciences Inc. Between 1 August 2018 and 25 August 2025, the trades on record add up to 24 filings.
The open-market side counts 14 purchases for €6.3M alongside 1 sale for €42.7M. No amount is published for 1 filing, which the totals therefore leave out. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2025: 1 purchase and 1 sale on the market.
The median purchase comes to €399k. Clusters matter here: 13 out of 13 purchases overlapped with buying by a colleague within 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. After 13 purchases with a full 90-day history, the hit rate stands at 69% and the median 90-day move at +188.0%. These figures describe past trades and do not predict future prices.
The record was last updated on 27 August 2025 with an open-market sale (€42.7M) in Ascletis Pharma Inc. - B. The last insider purchase was made public on 13 January 2025, 665 days ago. The median gap between a trade and its publication by SEC (Form 4) is 4 days. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Wu Jinzi Jason
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 23,580,000 shares@ HK$16.4587.1% of flowShareXHKGHKEX:DA20250827E00010
- 300,000 shares@ HK$3.05480.2% of flowShareXHKGHKEX:DA20250113E00293Canonical exit: 9 Apr 2025 (T+90)
- 3,973,000 shares@ HK$1.66431.6% of flowShareXHKGHKEX:DA20241217E00375Canonical exit: 18 Feb 2025 (T+90)
- 6,043,000 shares@ HK$1.44262.1% of flowShareXHKGHKEX:DA20241217E00372Canonical exit: 2 Feb 2025 (T+90)
- 2,400,000 shares@ HK$1.26520.7% of flowShareXHKGHKEX:DA20241217E00370Canonical exit: 14 Jan 2025 (T+90)
- 7,470,000 shares@ HK$1.38962.5% of flowShareXHKGHKEX:DA20241217E00369Canonical exit: 6 Jan 2025 (T+90)
- 3,189,000 shares@ HK$0.97460.7% of flowShareXHKGHKEX:DA20241217E00368Canonical exit: 23 Dec 2024 (T+90)
- 3,977,000 shares@ HK$0.93610.9% of flowShareXHKGHKEX:DA20241217E00367Canonical exit: 15 Dec 2024 (T+90)
- 5,324,000 shares@ HK$0.98991.2% of flowShareXHKGHKEX:DA20241217E00366Canonical exit: 8 Dec 2024 (T+90)
- 4,363,000 shares@ HK$1.15941.2% of flowShareXHKGHKEX:DA20241217E00364Canonical exit: 23 Oct 2024 (T+90)
- 1,155,500 sharesShareXHKGHKEX:DA20240115E00011
- 1,000,000 sharesShareXHKGHKEX:DA20240105E00128Canonical exit: 2 Apr 2024 (T+90)
- 1,654,701 sharesSeries A Common StockSEC:0001104659-23-082735:0
- 0ShareXHKGHKEX:DA20220905E00636
- 38,000,000 sharesShareXHKGHKEX:DA20220831E00284
- 44,827,414 sharesShareXHKGHKEX:DA20200813E00356
- 1,142,000 shares@ HK$3.050.8% of flowShareXHKGHKEX:DA20191017E00409Canonical exit: 15 Jan 2020 (T+90)
- 529,000 shares@ HK$2.99540.4% of flowShareXHKGHKEX:DA20191017E00410Canonical exit: 14 Jan 2020 (T+90)
- 296,000 shares@ HK$2.99490.2% of flowShareXHKGHKEX:DA20191017E00411Canonical exit: 13 Jan 2020 (T+90)
- 344,000 shares@ HK$3.00120.2% of flowShareXHKGHKEX:DA20191017E00412Canonical exit: 12 Jan 2020 (T+90)
- 552,393,664 sharesShareXHKGHKEX:DA20191014E00298
- 0ShareXHKGHKEX:DA20190806E00390
- 17,393,000 sharesShareXHKGHKEX:DA20180828E00445
- 597,221,078 sharesShareXHKGHKEX:DA20180814E00366
24 of 24 declarations
